Stem cell and platelet rich plasma (PRP) therapies are considered as regenerative or bio medicines. They are minimally invasive and hence reduce the need for surgery. These therapies help stimulate, rebuild, and strengthen hair regrowth, instead of removing damaged tissue from the scalp.
Novel therapies for alopecia are preferred by dermatologists and patients over conventional drugs such as corticosteroids. Greater preference for these therapies arises from efficient and faster hair regrowth as compared to other corticosteroid treatments.

Market Analysis and Insights: Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market
The global Platelet Rich Plasma and Stem Cell Alopecia Treatment market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Scope and Market Size
The global Platelet Rich Plasma and Stem Cell Alopecia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Platelet Rich Plasma and Stem Cell Alopecia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Androgenic Alopecia
Congenital Alopecia
Cicatricial Or Scarring Alopecia

Segment by Application
Hospital
Dermatology Clinic
Other

The Platelet Rich Plasma and Stem Cell Alopecia Treatment market is analysed and market size information is provided by regions (countries). Segment by Application, the Platelet Rich Plasma and Stem Cell Alopecia Treatment market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Kerastem
Eclipse
Regen Lab SA
Stemcell Technologies
RepliCel Life Sciences
Histogen
Glofinn Oy.